<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There are chemotherapy methods applied before operation, before and after operation, or after operation for <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>But the correct times and periods, etc., for their administration have not been obvious </plain></SENT>
<SENT sid="2" pm="."><plain>We perform maximum preoperative chemotherapy to control micrometastases, and afterwards surgically remove the metastatic lesions[including radiofrequency ablation(RFA)] </plain></SENT>
<SENT sid="3" pm="."><plain>Complications after operation and the severity of pathological liver damage etc., were investigated by comparing 14 patients who received maximum preoperative chemotherapy(group A), with 4 patients for whom 6 courses of FOLFOX+bevacizumab(BV)therapy(group B)were planned </plain></SENT>
<SENT sid="4" pm="."><plain>ICG15 before liver resection and <z:mp ids='MP_0001914'>bleeding</z:mp> during liver resection were not significantly different(p=0 </plain></SENT>
<SENT sid="5" pm="."><plain>26 and p=0 </plain></SENT>
<SENT sid="6" pm="."><plain>60, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>No severe complication after operation was seen and pathological liver damage was minor in both groups </plain></SENT>
<SENT sid="8" pm="."><plain>No interference of maximum preoperative chemotherapy with BV to <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> was suggested from the point of view of complications after operation and the severity of pathological liver damage </plain></SENT>
<SENT sid="9" pm="."><plain>Further investigation with many more patients is necessary </plain></SENT>
</text></document>